English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

autoimmune target in alopecia areata. J Am Acad Dermatol. 2009;61(3):529530. 13. Nagai H, Oniki S, Oka M, Horikawa T, Nishigori C. Induction of cellular immunity against hair follicle melanocyte causes alopecia. Arch Dermatol Res. 2006; 298(3):131-134. 14. Au WY, Yeung CK, Chan HH, Lie AK. Generalized vitiligo after lymphocyte infusion for relapsed leukaemia. Br J Dermatol. 2001;145(6):1015-1017. 15. Nagler A, Goldenhersh MA, Levi-Schaffer F, Bystryn JC, Klaus SN. Total leucoderma: a rare manifestation of cutaneous chronic graft-versus-host disease. Br J Dermatol. 1996;134(4):780-783. 16. Sanli H, Akay BN, Arat M, et al. Vitiligo after hematopoietic cell transplantation: six cases and review of the literature. Dermatology. 2008;216(4):349-354. 17. Motl SE, Fausel C. Recurring chemotherapy-associated alopecia areata: case report and literature review. Pharmacotherapy. 2003;23(1):104-108. 18. Brazzelli V, Roveda E, Prestinari F, et al. Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment. Pediatr Dermatol. 2006;23(2):175-178. 19. Mariani S, Abruzzese E, Basciani S, et al. Reversible hair depigmentation in a patient treated with imatinib [published online December 19, 2010]. Leuk Res. 2010;35(6):e64-e66. doi:10.1016/j.leukres.2010.11.028. 20. Raanani P, Goldman JM, Ben-Bassat I. Challenges in oncology: case 3: depigmentation in a chronic myeloid leukemia patient treated with STI-571. J Clin Oncol. 2002;20(3):869-870. 21. Routhouska S, Gilliam AC, Mirmirani P. Hair depigmentation during chemotherapy with a class III/V receptor tyrosine kinase inhibitor. Arch Dermatol. 2006; 142(11):1477-1479. 22. Huang CL, Kuo TT, Chan HL. Acquired generalized hypohidrosis/anhidrosis with subclinical Sjögren’s syndrome: report of a case with diffuse syringolymphoid hyperplasia and lymphocytic sialadenitis. J Am Acad Dermatol. 1996;35(2, pt 2):350-352. 23. Akosa AB, Lampert IA. The sweat gland in graft versus host disease. J Pathol. 1990;161(3):261-266. 24. Cheshire WP, Fealey RD. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management. Drug Saf. 2008;31(2):109-126. 25. Häusermann P, Walter RB, Halter J, et al. Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology. 2008;216(4):287-304.

Top-Accessed Article: Skin Markers of Occult Spinal Dysraphism in Children